HIV Citation List: February 28 - March 13, 2014

PubMed citations

1. Highly Active Antiretroviral Therapies are Effective against HIV-1 Cell-to-cell Transmission. Agosto, L.M., P. Zhong, J. Munro, and W. Mothes. Plos Pathogens, 2014. 10(2): p. e1003982. PMID[24586176].

[PubMed]. HIV_0228-031314.

2. Long-acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus. Andrews, C.D., W.R. Spreen, H. Mohri, L. Moss, S. Ford, A. Gettie, K. Russell-Lodrigue, R.P. Bohm, C. Cheng-Mayer, Z. Hong, M. Markowitz, and D.D. Ho. Science, 2014. 343(6175): p. 1151-1154. PMID[24594934].

[PubMed]. HIV_0228-031314.

3. Engineering a Switch-on Peptide to Ricin A Chain for Increasing Its Specificity Towards HIV-infected Cells. Au, K.Y., R.R. Wang, Y.T. Wong, K.B. Wong, Y.T. Zheng, and P.C. Shaw. Biochimica Biophysica Acta, 2014. 1840(3): p. 958-963. PMID[24246953].

[PubMed]. HIV_0228-031314.

4. Biological Activity of Sporolides A and B from Salinispora tropica: In Silico Target Prediction Using Ligand-based Pharmacophore Mapping and in Vitro Activity Validation on HIV-1 Reverse Transcriptase.Dineshkumar, K., V. Aparna, K.Z. Madhuri, and W. Hopper. Chemical Biology & Drug Design, 2014. 83(3): p. 350-361. PMID[24165098].

[PubMed]. HIV_0228-031314.

5. Cytotoxic and HIV-1 Enzyme Inhibitory Activities of Red Sea Marine Organisms.Ellithey, M.S., N. Lall, A.A. Hussein, and D. Meyer. BMC Complementary and Alternative Medicine, 2014. 14(1): p. 77. PMID[24568567].

[PubMed]. HIV_0228-031314.

6. GS-8374, a Prototype Phosphonate-containing Inhibitor of HIV-1 Protease, Effectively Inhibits Protease Mutants with Amino acid Insertions.Grantz Saskova, K., M. Kozisek, K. Stray, D. de Jong, P. Rezacova, J. Brynda, N.M. van Maarseveen, M. Nijhuis, T. Cihlar, and J. Konvalinka. Journal of Virology, 2014. 88(6): p. 3586-3590. PMID[24371077]. .

[PubMed]. HIV_0228-031314.

7. In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor. Lai, M.T., M. Feng, J.P. Falgueyret, P. Tawa, M. Witmer, D. Distefano, Y. Li, J. Burch, N. Sachs, M. Lu, E. Cauchon, L.C. Campeau, J. Grobler, Y. Yan, Y. Ducharme, B. Cote, E. Asante-Appiah, D.J. Hazuda, and M.D. Miller. Antimicrobial Agents and Chemotherapy, 2014. 58(3): p. 1652-1663. PMID[24379202].

[PubMed]. HIV_0228-031314.

8. Semi-synthesis of Acylated triterpenes from Olive-oil Industry Wastes for the Development of Anticancer and anti-HIV Agents. Parra, A., S. Martin-Fonseca, F. Rivas, F.J. Reyes-Zurita, M. Medina-O'Donnell, A. Martinez, A. Garcia-Granados, J.A. Lupianez, and F. Albericio. European Journal of Medicinal Chemistry, 2014. 74: p. 278-301. PMID[24480359].

[PubMed]. HIV_0228-031314.

9. A Double-mimetic Peptide Efficiently Neutralizes HIV-1 by Bridging the CD4- and Coreceptor-binding Sites of gp120. Quinlan, B.D., V.R. Joshi, M.R. Gardner, K.H. Ebrahimi, and M. Farzan. Journal of Virology, 2014. 88(6): p. 3353-3358. PMID[24390333].

[PubMed]. HIV_0228-031314.

10. R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced from Latently Infected Cells. Wang, X., Z. Ao, K. Danappa Jayappa, B. Shi, G. Kobinger, and X. Yao. Molecular therapy. Nucleic acids, 2014. 3: p. e151. PMID[24594845].

[PubMed]. HIV_0228-031314.

ISI Web of Knowledge Citations

11. Synthesis of Novel Pyrazolobenzothiazine 5,5-dioxide Derivatives as Potent anti-HIV-1 Agents. Ahmad, M., S. Aslam, M.H. Bukhari, C. Montero, M. Detorio, M. Parvez, and R.F. Schinazi. Medicinal Chemistry Research, 2014. 23(3): p. 1309-1319. ISI[000330768100022].

[WOS]. HIV_0228-031314.

12. Improvement of the HIV Fusion Inhibitor C34 Activity by Membrane Anchoring and Enhanced Exposure. Augusto, M.T., A. Hollmann, M. Castanho, A. Pessi, and N.C. Santos. European Biophysics Journal with Biophysics Letters, 2013. 42: p. S165-S165. ISI[000330215300497].

[WOS]. HIV_0228-031314.

13. On the Reaction Products of 4-Substituted 3-Pyridinesulfonamides with Some Benzenesulfonyl chloride Derivatives.Brzozowski, Z., J. Slawinski, and K. Szafranski. Journal of Heterocyclic Chemistry, 2014. 51(1): p. 11-17. ISI[000330163300002].

[WOS]. HIV_0228-031314.

14. Linker-extended Native Cyanovirin-N Facilitates PEGylation and Potently Inhibits HIV-1 by Targeting the Glycan Ligand.Chen, J., D.E. Huang, W. Chen, C.W. Guo, B. Wei, C.C. Wu, Z. Peng, J. Fan, Z.B. Hou, Y.S. Fang, Y.F. Wang, K. Kitazato, G.Y. Yu, C.B. Zou, C.W. Qian, and S. Xiong. PloS One, 2014. 9(1): p. e86455. ISI[000330507300065].

[WOS]. HIV_0228-031314.

15. Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase P110 Alpha That Reactivates Latent HIV-1. Doyon, G., M.D. Sobolewski, K. Huber, D. McMahon, J.W. Mellors, and N. Sluis-Cremer. PloS One, 2014. 9(1): p. e84964. ISI[000330570000008].

[WOS]. HIV_0228-031314.

16. The Synthesis, Antiviral, Cytostatic and Cytotoxic Evaluation of a New Series of Acyclonucleotide Analogues with a 1,2,3-Triazole Linker.Glowacka, I.E., J. Balzarini, and A.E. Wroblewski. European Journal of Medicinal Chemistry, 2013. 70: p. 703-722. ISI[000330554400067].

[WOS]. HIV_0228-031314.

17. The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-dependent, Broad-spectrum Inhibitor of HIV-1. Guzzo, C., J. Fox, Y. Lin, H.Y. Miao, R. Cimbro, B.F. Volkman, A.S. Fauci, and P. Lusso. Plos Pathogens, 2013. 9(12): p. e1003852. ISI[000330535400062]. .

[WOS]. HIV_0228-031314.

18. Dynamins are Forever: MxB Inhibits HIV-1.Haller, O. Cell Host & Microbe, 2013. 14(4): p. 371-373. ISI[000330852900002].

[WOS]. HIV_0228-031314.

19. Dithiocarbamates as Precursors in Organic Chemistry; Synthesis and Uses.Hassan, E.A. and S.E. Zayed. Phosphorus Sulfur and Silicon and the Related Elements, 2014. 189(3): p. 300-323. ISI[000330265700002].

[WOS]. HIV_0228-031314.

20. New HIV Fusion Inhibitors LJ001 and JL103 Act by Modifying Viral Lipid Membrane Properties. Hollmann, A., F. Vigant, M. Castanho, B. Lee, and N.C. Santos. European Biophysics Journal with Biophysics Letters, 2013. 42: p. S123-S123. ISI[000330215300340].

[WOS]. HIV_0228-031314.

21. Cytolytic Nanoparticles Attenuate HIV-1 Infectivity.Hood, J.L., A.P. Jallouk, N. Campbell, L. Ratner, and S.A. Wickline. Antiviral Therapy, 2013. 18(1): p. 95-103. ISI[000329575900011].

[WOS]. HIV_0228-031314.

22. A New Dibenzocyclooctadiene Lignan from Stems of Schisandra lancifolia and Its Bioactivities. Li, Y.K., X.X. Wu, M. Li, G. Du, Q.F. Hu, and X.M. Gao. Asian Journal of Chemistry, 2014. 26(1): p. 224-226. ISI[000330294400051].

[WOS]. HIV_0228-031314.

23. HIV-1 Variants with Mutations in the gp41 Pocket Region are Resistant to HIV Fusion Inhibitors with Pocket-binding Domain, but Sensitive to T20.Lua, L., P. Tong, X.W. Yu, C.G. Pan, P. Zou, Y.H. Chen, and S.B. Jiang. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 2013. 62: p. 65-65. ISI[000330458000065].

[WOS]. HIV_0228-031314.

24. Design, Synthesis and Biological Evaluation of Phosphorodiamidate Prodrugs of Antiviral and Anticancer Nucleosides.McGuigan, C., C. Bourdin, M. Derudas, N. Hamon, K. Hinsinger, S. Kandil, K. Madela, S. Meneghesso, F. Pertusati, M. Serpi, M. Slusarczyk, S. Chamberlain, A. Kolykhalov, J. Vernachio, C. Vanpouille, A. Introini, L. Margolis, and J. Balzarini. European Journal of Medicinal Chemistry, 2013. 70: p. 326-340. ISI[000330554400028].

[WOS]. HIV_0228-031314.

25. Molecular Docking Studies of Marine Diterpenes as Inhibitors of Wild-type and Mutants HIV-1 Reverse Transcriptase.Miceli, L.A., V.L. Teixeira, H.C. Castro, C.R. Rodrigues, J.F.R. Mello, M.G. Albuquerque, L.M. Cabral, M.A. de Brito, and A.M.T. de Souza. Marine Drugs, 2013. 11(11): p. 4127-4143. ISI[000330521400001].

[WOS]. HIV_0228-031314.

26. Synthesis of A-pentacyclic Triterpene alpha,beta-Alkenenitriles.Pereslavtseva, A.V., I.A. Tolmacheva, P.A. Slepukhin, O.S. El'tsov, Kucherov, II, V.F. Eremin, and V.V. Grishko. Chemistry of Natural Compounds, 2014. 49(6): p. 1059-1066. ISI[000330713200017].

[WOS]. HIV_0228-031314.

27. Fucoidans as Potential Inhibitors of HIV-1.Prokofjeva, M.M., T.I. Imbs, N.M. Shevchenko, P.V. Spirin, S. Horn, B. Fehse, T.N. Zvyagintseva, and V.S. Prassolov. Marine Drugs, 2013. 11(8): p. 3000-3014. ISI[000330521300020].

[WOS]. HIV_0228-031314.

28. Iminophosphoranes in Heterocyclic Synthesis: Synthesis of Pyrazolo[1,5-a]pyrimidines, Imidazo[1,2-b]pyrazole and Pyrazolo[1,5-b][1,2,4]triazine Derivatives via Intermolecular Aza-Wittig Reactions.Raslan, M., M. Khalil, and S.M. Sayed. Heterocycles, 2013. 87(12): p. 2567-2576. ISI[000330487600007].

[WOS]. HIV_0228-031314.

29. Synthesis and Antiviral Activity of C-3(C-28)-substituted 2,3-Seco-triterpenoids. Tolmacheva, I.A., E.V. Igosheva, O.V. Savinova, E.I. Boreko, and V.V. Grishko. Chemistry of Natural Compounds, 2014. 49(6): p. 1050-1058. ISI[000330713200016].

[WOS]. HIV_0228-031314.

30. Virus Inhibition Induced by Polyvalent Nanoparticles of Different Sizes. Vonnemann, J., C. Sieben, C. Wolff, K. Ludwig, C. Bottcher, A. Herrmann, and R. Haag. Nanoscale, 2014. 6(4): p. 2353-2360. ISI[000330796700050].

[WOS]. HIV_0228-031314.

31. A Novel Ribonuclease with Antiproliferative Activity toward Leukemia and Lymphoma Cells and HIV-1 Reverse Transcriptase Inhibitory Activity from the Mushroom, Hohenbuehelia serotina. Zhang, R., L.Y. Zhao, H.X. Wang, and T.B. Ng. International Journal of Molecular Medicine, 2014. 33(1): p. 209-214. ISI[000330785400027].

[WOS]. HIV_0228-031314.